BIOLASE, Inc. – NASDAQ:BIOL

BIOLASE stock price today

$0.058
-0.02
-29.15%
Financial Health
0
1
2
3
4
5
6
7
8
9

BIOLASE stock price monthly change

-44.97%
month

BIOLASE stock price quarterly change

-54.90%
quarter

BIOLASE stock price yearly change

+0.12%
year

BIOLASE key metrics

Market Cap
731.94K
Enterprise value
N/A
P/E
-0.06
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
0.04
Price/Book
0.41
PEG ratio
N/A
EPS
-14.94
Revenue
48.82M
EBITDA
-14.54M
Income
-21.26M
Revenue Q/Q
-3.21%
Revenue Y/Y
0.13%
Profit margin
-59.09%
Oper. margin
-52.29%
Gross margin
32.83%
EBIT margin
-52.29%
EBITDA margin
-29.78%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BIOLASE stock price history

BIOLASE stock forecast

BIOLASE financial statements

BIOLASE, Inc. (NASDAQ:BIOL): Profit margin
Jun 2023 14.28M -4.86M -34.08%
Sep 2023 10.92M -4.58M -42.02%
Dec 2023 13.49M -5.32M -39.48%
Mar 2024 10.13M -6.48M -64.01%
BIOLASE, Inc. (NASDAQ:BIOL): Analyst Estimates
Mar 2024 10.13M -6.48M -64.01%
Sep 2025 12.5M -60.62K -0.48%
Oct 2025 12.45M -356.84K -2.87%
Dec 2025 17.1M 178.42K 1.04%
  • Analysts Price target

  • Financials & Ratios estimates

BIOLASE, Inc. (NASDAQ:BIOL): Debt to assets
Jun 2023 39633000 32.29M 81.48%
Sep 2023 38745000 32.86M 84.81%
Dec 2023 35101000 35.34M 100.7%
Mar 2024 34353000 36.28M 105.63%
BIOLASE, Inc. (NASDAQ:BIOL): Cash Flow
Jun 2023 -3.56M -357K 4.27M
Sep 2023 -2.58M -182K 3.75M
Dec 2023 -2.28M -3K 885K
Mar 2024 -5.93M 197K 5.64M

BIOLASE alternative data

BIOLASE, Inc. (NASDAQ:BIOL): Employee count
Aug 2023 188
Sep 2023 188
Oct 2023 188
Nov 2023 188
Dec 2023 188
Jan 2024 188
Feb 2024 188
Mar 2024 157
Apr 2024 157
May 2024 157
Jun 2024 157
Jul 2024 157

BIOLASE other data

23.94% +12.45%
of BIOL is owned by hedge funds
1.45M +756.56K
shares is hold by hedge funds

BIOLASE, Inc. (NASDAQ:BIOL): Insider trades (number of shares)
Period Buy Sel
Dec 2022 0 3537
Transaction Date Insider Security Shares Price per share Total value Source
Sale
LORD JONATHAN T MD director
Common Stock 3,537 $0.75 $2,653
Sale
LORD JONATHAN T MD director
Common Stock 11,038 $0.38 $4,194
Purchase
BEAVER JOHN R director, officer.. Common Stock 70,000 $0.45 $31,500
Purchase
BEAVER JOHN R officer: EVP & Ch.. Common Stock 35,000 $0.61 $21,350
Purchase
BEAVER JOHN R officer: EVP & Ch.. Common Stock 40,000 $0.75 $30,000
Sale
FEINBERG LARRY N 10 percent owner
Common Stock 1,759,912 $0.55 $969,712
Sale
FEINBERG LARRY N 10 percent owner
Common Stock 1,759,912 $0.55 $969,712
Sale
FEINBERG LARRY N 10 percent owner
Common Stock 923,482 $0.55 $511,609
Sale
FEINBERG LARRY N 10 percent owner
Common Stock, par value $0.001 per share ("Common Stock") 2,479,456 $0.55 $1,373,619
Sale
SCHULER JACK W 10 percent owner
Common Stock 1,307,931 $0.6 $784,759
Patent
Application
Filling date: 4 Jan 2022 Issue date: 30 Jun 2022
Application
Filling date: 4 Oct 2021 Issue date: 30 Jun 2022
Application
Filling date: 17 Nov 2021 Issue date: 16 Jun 2022
Application
Filling date: 15 Nov 2021 Issue date: 10 Mar 2022
Grant
Filling date: 25 Nov 2020 Issue date: 15 Feb 2022
Application
Filling date: 17 Aug 2021 Issue date: 3 Feb 2022
Application
Filling date: 3 Aug 2021 Issue date: 27 Jan 2022
Application
Filling date: 28 Jul 2021 Issue date: 20 Jan 2022
Grant
Filling date: 21 Dec 2017 Issue date: 21 Dec 2021
Grant
Filling date: 21 Oct 2019 Issue date: 7 Dec 2021
Tuesday, 1 October 2024
accesswire.com
Thursday, 8 August 2024
accesswire.com
Tuesday, 18 June 2024
accesswire.com
Monday, 13 May 2024
Seeking Alpha
Monday, 6 May 2024
Accesswire
Thursday, 14 March 2024
Accesswire
Friday, 9 February 2024
Benzinga
Friday, 4 August 2023
Benzinga
Friday, 12 May 2023
InvestorPlace
Thursday, 20 April 2023
PennyStocks
Tuesday, 28 March 2023
Seeking Alpha
Monday, 13 March 2023
PRNewsWire
Thursday, 16 February 2023
PRNewsWire
Monday, 14 November 2022
PRNewsWire
Thursday, 10 November 2022
Seeking Alpha
Thursday, 27 October 2022
PRNewsWire
Thursday, 11 August 2022
Seeking Alpha
Thursday, 28 July 2022
PRNewsWire
Thursday, 2 June 2022
PRNewsWire
Thursday, 12 May 2022
Seeking Alpha
Thursday, 17 March 2022
Seeking Alpha
Thursday, 3 March 2022
PRNewsWire
Tuesday, 11 January 2022
Seeking Alpha
Sunday, 2 January 2022
PennyStocks
Friday, 31 December 2021
InvestorPlace
Monday, 27 December 2021
PennyStocks
Tuesday, 7 December 2021
PennyStocks
Friday, 3 December 2021
PennyStocks
Pulse2
Friday, 26 November 2021
PennyStocks
  • What's the price of BIOLASE stock today?

    One share of BIOLASE stock can currently be purchased for approximately $0.06.

  • When is BIOLASE's next earnings date?

    Unfortunately, BIOLASE's (BIOL) next earnings date is currently unknown.

  • Does BIOLASE pay dividends?

    No, BIOLASE does not pay dividends.

  • How much money does BIOLASE make?

    BIOLASE has a market capitalization of 731.94K and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.45% to 49.16M US dollars.

  • What is BIOLASE's stock symbol?

    BIOLASE, Inc. is traded on the NASDAQ under the ticker symbol "BIOL".

  • What is BIOLASE's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of BIOLASE?

    Shares of BIOLASE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are BIOLASE's key executives?

    BIOLASE's management team includes the following people:

    • Mr. John R. Beaver Pres, Chief Executive Officer & Director(age: 64, pay: $309,830)
  • How many employees does BIOLASE have?

    As Jul 2024, BIOLASE employs 157 workers.

  • When BIOLASE went public?

    BIOLASE, Inc. is publicly traded company for more then 32 years since IPO on 12 Nov 1992.

  • What is BIOLASE's official website?

    The official website for BIOLASE is biolase.com.

  • Where are BIOLASE's headquarters?

    BIOLASE is headquartered at 27042 Towne Centre Drive, Foothill Ranch, CA.

  • How can i contact BIOLASE?

    BIOLASE's mailing address is 27042 Towne Centre Drive, Foothill Ranch, CA and company can be reached via phone at +94 93611200.

BIOLASE company profile:

BIOLASE, Inc.

biolase.com
Exchange:

NASDAQ

Full time employees:

157

Industry:

Medical - Devices

Sector:

Healthcare

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

27042 Towne Centre Drive
Foothill Ranch, CA 92610-2811

CIK: 0000811240
ISIN: US0909117022
CUSIP: 090911207